Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease
Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups, demonstrating a favorable PK profile in validating gut-restrictive properties. Supported by Insilico's...
Massimo Motor Expands Nationwide Reach with 6th Distribution Center in Illinois
Midwest hub to support Massimo's robust network of partners and customers in the region GARLAND, Texas, Jan. 7, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo"), a manufacturer and distributor of powersports vehicles and pontoon boats,...
Moomoo Announces Global Partnership With Seeking Alpha to Amplify Trading Potential for Investors
JERSEY CITY, N.J., Jan. 7, 2025 /PRNewswire/ -- Moomoo, one of the world's leading investment and trading platforms, today announced its partnership with Seeking Alpha, a leading financial research platform powered by one of the world's largest...
Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma
Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). The partnership with IFLI will accelerate the clinical development of SynKIR™-310 in Follicular Lymphoma (FL) by leveraging...
Segway Officially Recognized as Global No.1 Brand in eKickScooter Sales
Micromobility leader announces verified milestone as it debuts new models during CES 2025 LAS VEGAS, Jan. 7, 2025 /PRNewswire/ -- Segway, the global leader in micromobility transportation solutions, has been recognized as the "global No.1 brand of...
GORTEC Announces New Trial Success for Head and Neck Cancer Treatment
TOURS, France, Jan. 7, 2025 /PRNewswire/ -- GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as a...
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment
TAMPA, Fla., Jan. 7, 2025 /PRNewswire/ -- Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIRO limus versus Paclitaxel Drug-Eluting Balloo N...
Coway Announces Expansion of Shareholder Return Policy
Total Shareholder Return Rate* Increase: Doubling from 20% to 40% through 2027 to enhance shareholder value. Dividend Increase and Share Cancellation: For FY2024, cash dividends will more than double compared to the previous year, and 2.56% of all...
Acer Announces Predator Helios AI Laptops with New Intel Core Ultra Processors and NVIDIA GeForce RTX 50 Series Laptop GPUs
Acer also announced the all-new slim Predator Helios Neo 16S AI laptop and Predator XB323QX gaming monitor Editor's Summary The powerful Predator Helios 16 AI and Predator Helios 18 AI support up to Intel® Core™ Ultra 9 processor 275HX and next-gen...
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager
SHANGHAI and SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced an agreement with Candid Therapeutics, Inc....